Completed PHASE3 INTERVENTIONAL 2-arm NCT00297882

Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon

Phase III Clinical Trials of Artemisinin-based Combination Therapy in Cameroon

Sponsor: Cameroon Baptist Convention Health

Conditions Malaria

Interventions 1. Artemether-Lumefantrine (AL) 2. Amodiaquine-Artesunate (AQ-AS)

Updated 7 times since 2017 Last updated: May 13, 2021 Started: Jul 31, 2006 Primary completion: Apr 30, 2009 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Malaria and is currently completed. Cameroon Baptist Convention Health leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Dec 2021 — Jul 2024 [monthly]

Completed PHASE3
Sep 2021 — Dec 2021 [monthly]

Completed PHASE3
Jan 2021 — Sep 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cameroon Baptist Convention Health
London School of Hygiene and Tropical Medicine
University of Yaounde

Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.